Targeting IL-1, IL-22, and chemokine pathways Despite evidence that IL-1 significantly contributes to the progression of ALD in experimental models, clinical trials using IL-1 receptor antagonists [253] (anakinra, NCT01809132) and monoclonal antibodies [254] (canakinumab, NCT03775109) for severe AH have not demonstrated positive outcomes
All individuals, healthy or otherwise, can benefit from oral dosing of NAD+ precursors such as Nicotinamide Riboside
Wikipedia Insulin-like Growth Factor 1 (IGF-1) Comprehensive overview of IGF-1 biology, receptor interaction, and cellular signalling
A mutation in the FMO3 gene affects the FMO3 enzyme
Each serving of Liposomal Glutathione is designed to help you protect your cells from oxidative damage and from the daily onslaught of free radicals